This site is intended for healthcare professionals

TV

Keep up to date with the latest developments on a variety of subjects and expertise with our videos. You can claim CPD credits by watching.

  • Progestogens and risk of intracranial meningioma

  • Chronic kidney disease risk assessment, referral criteria and pharmacotherapy: NICE guidance (part 2)

  • Valproate prescribing: guidance from the Health Products Regulatory Agency (Ireland)

  • Paternal metformin use and risk of congenital malformations

  • Electronic nudges for influenza vaccination

  • Assessment and management of chronic kidney disease: NICE guidance (part 1)

    • title

      label
    • title

      label
    • title

      label
    • title

      label
    • title

      label
    • title

      label
    • title

      label
    • title

      label
    • title

      label
    • title

      label
    • title

      label
    • title

      label

    More resources

    • Pages

      More than 30,000 concise, interlinked clinical reference articles, each focused on a specific primary care topic.

    • Podcast

      A growing library of more than 70 bite-sized podcast episodes, each covering a specific clinical scenario. Released on a fortnightly basis and accessible on the go from your favourite podcast platform.

    • Shortcuts

      Free, downloadable aide-mémoires in PDF format. Each summarises key facts and guidance on a complex clinical topic.

    The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

    Connect

    Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.